Search Results - MOLTHROP, D. C

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Evaluation of the methemoglobinemia associated with sulofenur

    Evaluation of the methemoglobinemia associated with sulofenur by MOLTHROP, D. C, WHEELER, R. H, HALL, K. M, PRCHAL, J. T

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Phase I and pharmacologic study of 7- and 21-day continuous etoposide infusion in patients with advanced cancer

    Phase I and pharmacologic study of 7- and 21-day continuous etoposide infusion in patients with advanced cancer by ROBERT, F, CHEN, S, MILLER, A. A, LEE, B. C, MOLTHROP, D. C, WHEELER, R. H

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Abstract P1-12-04: A phase 2 study of eribulin in breast cancer not achieving a pathologic complete response (pCR) to neoadjuvant chemotherapy (NAC)

    Abstract P1-12-04: A phase 2 study of eribulin in breast cancer not achieving a pathologic complete response (pCR) to neoadjuvant chemotherapy (NAC) by Yardley, DA, Peacock, N, Shroff, S, Molthrop, DC, Anz, B, Daniel, BR, Young, RR, Weaver, R, Harwin, W, Webb, CD, Ward, P, Shastry, M, DeBusk, LM, Midha, R, Hainsworth, JD, Burris III, HA

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Abstract S1-02: Final analysis of a phase II 3-arm randomized trial of neoadjuvant trastuzumab or lapatinib or the combination of trastuzumab and lapatinib, followed by six cycles of docetaxel and carboplatin with trastuzumab and/or lapatinib in patients with HER2+ breast cancer (TRIO-US B07)

    Abstract S1-02: Final analysis of a phase II 3-arm randomized trial of neoadjuvant trastuzumab or lapatinib or the combination of trastuzumab and lapatinib, followed by six cycles... by Hurvitz, SA, Miller, JM, Dichmann, R, Perez, AT, Patel, R, Zehngebot, LM, Allen, H, Bosserman, LD, DiCarlo, BA, Kennedy, A, Giuliano, A, Calfa, CJ, Molthrop, DC, Mani, A, Dering, J, Wang, H-J, Adams, B, Martinez, D, Chen, H-W, Zoeller, J, Brugge, JS, Slamon, DJ

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Phase II trial of eribulin in patients who do not achieve pathologic complete response (pCR) following neoadjuvant chemotherapy

    Phase II trial of eribulin in patients who do not achieve pathologic complete response (pCR) following neoadjuvant chemotherapy by Yardley, Denise A., Peacock, Nancy, Daniel, Brooke, Anz, Betrand, Molthrop, David C., Shroff, Sonalee K., Young, Robyn, Jankov, Aleksander, Vander Woude, Amy, Shastry, Mythili, Pasek, Johanna, DeBusk, Laura M., Hainsworth, John D.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    A pilot study of adjuvant doxorubicin and cyclophosphamide followed by paclitaxel and sorafenib in women with node-positive or high-risk early-stage breast cancer

    A pilot study of adjuvant doxorubicin and cyclophosphamide followed by paclitaxel and sorafenib in women with node-positive or high-risk early-stage breast cancer by Spigel, David R, Hainsworth, John D, Burris, 3rd, Howard A, Molthrop, David C, Peacock, Nancy, Kommor, Michael, Vazquez, Elizabeth R, Greco, F Anthony, Yardley, Denise A

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: